Results 201 to 210 of about 56,774 (264)

The association between handedness and clinicodemographic characteristics in people with multiple sclerosis: A brief report [PDF]

, 2019
Cross, Anne H, Multiple Sclerosis Partners Advancing Technology and Health Solutions Investigators#,, Naismith, Robert T, Shirani, Afsaneh   +3 more
core   +1 more source

Alemtuzumab in relapsing-remitting multiple sclerosis

Schweizer Archiv für Neurologie und Psychiatrie, 2015
openaire   +1 more source

Serum neurofilament light chain as a biomarker of disease control in multiple sclerosis: a real-world cross-sectional analysis of therapeutic regimens. [PDF]

J Neurol
Konitsioti AM, Schweitzer F, Johannis W, Steffen F, Bittner S, Fink GR, Schroeter M, Warnke C.   +7 more
europepmc   +1 more source

Direct Medical Costs Associated with Multiple Sclerosis in Saudi Arabia: A Retrospective Single-Center Cost of Illness Analysis. [PDF]

Healthcare (Basel)
Alghamdi A, Almutairi H, Alnasser G, Alsoina S, Aljaber N.   +4 more
europepmc   +1 more source

Reconsidering Rehabilitation and Lifestyle Approaches to Improve Quality of Life in People with Multiple Sclerosis: A Scoping Review. [PDF]

Medicina (Kaunas)
Basalic EB, Roman NA, Minzatanu D, Manaila AI, Baseanu ICC, Miclaus RS.   +5 more
europepmc   +1 more source

The Value of Oligoclonal Bands in Multiple Sclerosis Compared to Other Neurological Disorders: A Retrospective Data Analysis From an Austrian Tertiary Center. [PDF]

Eur J Neurol
Monschein T, Scheicher B, Ponleitner M, Krajnc N, Föttinger F, Zrzavy T, Rommer P, Kornek B, Bsteh G, Perkmann T, Berger T, Leutmezer F.   +11 more
europepmc   +1 more source

Teriflunomide treatment for relapsing-remitting multiple sclerosis: An experience from Saudi Arabia. [PDF]

Medicine (Baltimore)
Aljinaid M, Khojah O, Arshad L, Algahtani R, Alghweinem Z, Alshehri S, Abulaban A, Al Malik Y, Makkawi S.   +8 more
europepmc   +1 more source

Mild cognitive impairment in relapsing-remitting multiple sclerosis

Annals of General Psychiatry, 2008
Dimakopoulou Aikaterini, Papamihalis Evaggelos, Petsanis Konstantinos, Floros George, Lagomatis-Lazopoulos George, Varsamopoulou Anastasia, Deretzi Georgia, Grigoriadis Nikolaos   +7 more
doaj   +1 more source

External validation of the budget impact analysis of the drug fingolimode in the treatment of multiple sclerosis. [PDF]

Cost Eff Resour Alloc
Campello CRS, da Costa MGS, Pinto M.
europepmc   +1 more source